The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MDS 2020 | Next-generation sequencing for low-risk MDS
Nicolas Bonadies
• 5 Mar 2020
Nicolas Bonadies, MD, Bern University Hospital, Bern, Switzerland, discusses the importance of next-generation sequencing (NGS) for the diagnosis, follow-up care and risk stratification of myelodysplastic syndrome (MDS) patients. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
